Literature DB >> 11418601

Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson.

J W Lawrence1, Y Li, S Chen, J G DeLuca, J P Berger, D R Umbenhauer, D E Moller, G Zhou.   

Abstract

We compared the ability of rat and human hepatocytes to respond to fenofibric acid and a novel potent phenylacetic acid peroxisome proliferator-activated receptor (PPAR) alpha agonist (compound 1). Fatty acyl-CoA oxidase (FACO) activity and mRNA were increased after treatment with either fenofibric acid or compound 1 in rat hepatocytes. In addition, apolipoprotein CIII mRNA was decreased by both fenofibric acid and compound 1 in rat hepatocytes. Both agonists decreased apolipoprotein CIII mRNA in human hepatocytes; however, very little change in FACO activity or mRNA was observed. Furthermore, other peroxisome proliferation (PP)-associated genes including peroxisomal 3-oxoacyl-CoA thiolase (THIO), peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (HD), peroxisomal membrane protein-70 (PMP-70) were not regulated by PPAR alpha agonists in human hepatocytes. Moreover, other genes that are regulated by PPAR alpha ligands in human hepatocytes such as mitochondrial HMG-CoA synthase and carnitine palmitoyl transferase-1 (CPT-1) were also regulated in HepG2 cells by PPAR alpha agonists. Several stably transfected HepG2 cell lines were established that overexpressed human PPAR alpha to levels between 6- and 26-fold over normal human hepatocytes. These PPAR alpha-overexpressing cells had higher basal mRNA levels of mitochondrial HMG-CoA synthase and CPT-1; however, basal FACO mRNA levels and other PP-associated genes including THIO, HD, or PMP-70 mRNA were not substantially affected. In addition, FACO, THIO, HD, and PMP-70 mRNA levels did not increase in response to PPAR alpha agonist treatment in the PPAR alpha-overexpressing cells, although mitochondrial HMG-CoA synthase and CPT-1 mRNAs were both induced. These results suggest that other factors besides PPAR alpha levels determine the species-specific response of human and rat hepatocytes to the induction of PP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418601     DOI: 10.1074/jbc.M103306200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs.

Authors:  Ya Xu; Li Lu; Clifford Greyson; Mona Rizeq; Karin Nunley; Beata Wyatt; Michael R Bristow; Carlin S Long; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-12-09       Impact factor: 4.733

2.  Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.

Authors:  B Dorfmeister; S Brandlhofer; F G Schaap; M Hermann; C Fürnsinn; B P Hagerty; H Stangl; W Patsch; W Strobl
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

Review 3.  Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

Authors:  Jeffrey M Peters; Connie Cheung; Frank J Gonzalez
Journal:  J Mol Med (Berl)       Date:  2005-06-23       Impact factor: 4.599

Review 4.  Genetic-dependency of peroxisomal cell functions - emerging aspects.

Authors:  N Latruffe; J Vamecq; M Cherkaoui Malki
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

5.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  Maryam Rakhshandehroo; Bianca Knoch; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2010-09-26       Impact factor: 4.964

6.  Tissue-selective, bidirectional regulation of PEX11 alpha and perilipin genes through a common peroxisome proliferator response element.

Authors:  Makoto Shimizu; Ayumi Takeshita; Toshiro Tsukamoto; Frank J Gonzalez; Takashi Osumi
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 7.  CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

Authors:  Katheryne Z Edson; Allan E Rettie
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 8.  Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors.

Authors:  Sven Francque; Gyongyi Szabo; Manal F Abdelmalek; Christopher D Byrne; Kenneth Cusi; Jean-François Dufour; Michael Roden; Frank Sacks; Frank Tacke
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-22       Impact factor: 46.802

9.  Delta6 desaturase mRNA abundance in HepG2 cells is suppressed by unsaturated fatty acids.

Authors:  Roxanne Portolesi; Barry C Powell; Robert A Gibson
Journal:  Lipids       Date:  2007-10-25       Impact factor: 1.880

10.  Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human.

Authors:  Maryam Rakhshandehroo; Guido Hooiveld; Michael Müller; Sander Kersten
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.